Skip to content
  • Tuesday, 29 September 2026
  • 10:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Culturally adapted lifestyle interventions significantly improve cognitive health in older Latin American adults according to the LatAm-FINGERS study.
Neuroscience & Brain Research

Culturally adapted lifestyle interventions significantly improve cognitive health in older Latin American adults according to the LatAm-FINGERS study.

Rifan Muazin Sep 27, 2026 0

The findings, unveiled at the Alzheimer’s Association International Conference (AAIC) 2026 in London and simultaneously published in the journal The…

Read More
Neuroscience & Brain Research

Culturally Tailored Lifestyle Interventions Significantly Boost Cognitive Health Across Latin America

Rifan Muazin Sep 19, 2026 0

A landmark two-year study involving over 1,000 older adults across 11 Latin American countries has provided compelling evidence that personalized,…

Read More
Neuroscience & Brain Research

Culturally Adapted Lifestyle Interventions Significantly Enhance Cognitive Health in Latin American Older Adults

Rifan Muazin Sep 11, 2026 0

A landmark two-year study involving over 1,000 older adults across 11 Latin American countries has provided robust evidence that personalized,…

Read More
Neuroscience & Brain Research

Placebo Interventions Demonstrate Significant Cognitive and Physical Benefits for Older Adults Even When Disclosed

Rifan Muazin Jun 26, 2026 0

A groundbreaking study conducted by psychologists at the Università Cattolica del Sacro Cuore in Milan has revealed that placebo interventions…

Read More
Osaka Metropolitan University Researchers Develop Self Regulating Artificial Photosynthesis System to Produce Solar Fuel Without Battery StorageUnraveling the Secrets of Peroxisome Growth: Plant Research Illuminates Human Health and Bioengineering PotentialThe Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access UncertaintiesMastering Data Science and Artificial Intelligence: A Comprehensive Guide to Five Free Open-Source Microsoft Curricula on GitHub
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ